Fortress Biotech Inc
General ticker "FBIO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $38.5M
Fortress Biotech Inc does not follow the US Stock Market performance with the rate: -7.5%.
Estimated limits based on current volatility of 2.6%: low 1.70$, high 1.79$
Factors to consider:
- Current price 33.9% below estimated low
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [4.06$, 11.67$]
- 2023-12-31 to 2024-12-30 estimated range: [2.74$, 7.77$]
Financial Metrics affecting the FBIO estimates:
- Negative: Non-GAAP EPS, $ of -17.85 <= 0.10
- Negative: Operating profit margin, % of -72.88 <= 1.03
- Negative: Operating cash flow per share per price, % of -76.16 <= 2.35
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -24.66 <= 1.31
Short-term FBIO quotes
Long-term FBIO plot with estimates
Financial data
YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|
Operating Revenue | $45.60MM | $68.79MM | $75.74MM |
Operating Expenses | $139.87MM | $257.33MM | $279.31MM |
Operating Income | $-94.27MM | $-188.54MM | $-203.56MM |
Non-Operating Income | $-8.58MM | $24.19MM | $-9.90MM |
Interest Expense | $9.70MM | $15.31MM | $13.64MM |
R&D Expense | $64.11MM | $128.87MM | $134.88MM |
Income(Loss) | $-102.85MM | $-164.35MM | $-213.46MM |
Taxes | $0.14MM | $0.47MM | $0.45MM |
Profit(Loss) | $-102.98MM | $-164.83MM | $-213.91MM |
Stockholders Equity | $100.34MM | $108.67MM | $41.72MM |
Inventory | $1.40MM | $9.86MM | $14.16MM |
Assets | $333.41MM | $396.50MM | $294.30MM |
Operating Cash Flow | $-83.68MM | $-116.54MM | $-179.40MM |
Capital expenditure | $7.16MM | $16.35MM | $3.06MM |
Investing Cash Flow | $-7.16MM | $40.51MM | $-22.93MM |
Financing Cash Flow | $172.41MM | $148.99MM | $75.32MM |
Earnings Per Share* | $-21.45 | $-30.26 | $-36.10 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.